Zhejiang Jolly Pharmaceutical Co Ltd
SZSE:300181

Watchlist Manager
Zhejiang Jolly Pharmaceutical Co Ltd Logo
Zhejiang Jolly Pharmaceutical Co Ltd
SZSE:300181
Watchlist
Price: 16.3 CNY -1.87%
Market Cap: 11.4B CNY
Have any thoughts about
Zhejiang Jolly Pharmaceutical Co Ltd?
Write Note
Zhejiang Jolly Pharmaceutical Co Ltd
/
Income Statement
/
Cost of Revenue

Zhejiang Jolly Pharmaceutical Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zhejiang Jolly Pharmaceutical Co Ltd
Cost of Revenue Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Zhejiang Jolly Pharmaceutical Co Ltd
SZSE:300181
Cost of Revenue
-¥865.8m
CAGR 3-Years
-28%
CAGR 5-Years
-23%
CAGR 10-Years
-31%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Cost of Revenue
-¥1B
CAGR 3-Years
-9%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Cost of Revenue
-¥5.9B
CAGR 3-Years
-15%
CAGR 5-Years
-14%
CAGR 10-Years
-24%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Cost of Revenue
-¥3.9B
CAGR 3-Years
1%
CAGR 5-Years
-6%
CAGR 10-Years
-11%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Cost of Revenue
-¥28.7B
CAGR 3-Years
-3%
CAGR 5-Years
-8%
CAGR 10-Years
-9%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Cost of Revenue
-¥242.3m
CAGR 3-Years
-6%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Zhejiang Jolly Pharmaceutical Co Ltd's Cost of Revenue?
Cost of Revenue
-865.8m CNY

Based on the financial report for Jun 30, 2024, Zhejiang Jolly Pharmaceutical Co Ltd's Cost of Revenue amounts to -865.8m CNY.

What is Zhejiang Jolly Pharmaceutical Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-31%

Over the last year, the Cost of Revenue growth was -44%. The average annual Cost of Revenue growth rates for Zhejiang Jolly Pharmaceutical Co Ltd have been -28% over the past three years , -23% over the past five years , and -31% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 193,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.